Assoc. Dir. DDIT DEV Data Analytics DS&AI Regular, Full time Information Technology India Hyderabad Office Nov 13, 2025 ...
Assoc. Dir. DDIT DEV Data Analytics DS&AI Regular, Full time Information Technology India Hyderabad Office Nov 13, 2025 Data Anonymization Analyst Regular, Full time Research India Hyderabad Office ...
Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...
First to have delivered at scale, Novartis fortifies leadership in RLT innovation and infrastructure with California facility, additional plans for Florida and Texas ...
V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...
Albania Alemania Angola Arabia Saudí Argelia Argentina Armenia Australia Austria Azerbaiyán Bahamas Bahráin Bangladesh Barbados Bélgica Benín Bermudas Bielorrusia Bolivia Bosnia-Herzegovina Brasil ...
At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...
استكشف الفرص مع نوفارتس أدناه.
Explore opportunities with Novartis below.
Select units of Cosentyx to be made available at 55% discount off list price on direct-to-patient (DTP) platform beginning November 1, 2025 DTP offering to expand to other appropriate products; ...
Novartis sodeluje z društvi bolnikov v Sloveniji in po vsem svetu, saj lahko le z medsebojnim sodelovanjem izboljšamo izide zdravljenja za bolnike in vpeljemo nove pristope k zdravljenju. Celovito ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果